Market Cap

AstraZeneca Market Capitalization:

AstraZeneca plc

£176.93 Billion

GBP as of July 1, 2023

US$224.80 Billion

business AstraZeneca Company Profile

AstraZeneca Main Stock Listing

show_chart LSE: AZN

Market capitalization history of AstraZeneca

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $417.05 B
Johnson & Johnson $412.24 B
Merck $275.82 B
Roche $241.08 B
AbbVie $239.18 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of AstraZeneca market cap

Date Market Cap YoY Change
Jan. 1, 2023 £180.79 B 34.62%
Jan. 1, 2022 £134.30 B 15.03%
Jan. 1, 2021 £116.75 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

AstraZeneca PLC is an Anglo–Swedish multinational pharmaceutical and biopharmaceutical company. AstraZeneca develops, manufactures, and sells pharmaceuticals and biotechnology products to treat major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

business AstraZeneca Company Profile

AstraZeneca Categories

United Kingdom languages Healthcare languages Drug Manufacturers—General
United Kingdom Healthcare United Kingdom Drug Manufacturers—General

Stocks & Indices

AstraZeneca plc has the following listings and related stock indices.


Stock: LSE: AZN

Stock: NASDAQ: AZN

Stock: BCBA: AZN

Stock: BMV: AZNN

Stock: FSX: ZEG

Stock: FSX: ZEGA

Stock: OMX: AZN

Stock: OTC: AZNCF

Stock: XETR: ZEG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.